Mutations that result in activation of other oncogenes and/or the inactivation of proteins that serve as tumor suppressors such as p53, p27, and phosphatase and tensin homologue (PTEN) [9,10] also contribute to the development of prostate cancer [11,12,13]. The gene discussed is PTEN; the disease is neoplasm.